Isomorphic Labs Raises $5 Billion Series C for AI Drug Design
Isomorphic Labs raised $5 billion in an oversubscribed Series C led by Greenoaks and Sequoia to scale its IsoDDE AI drug-design engine and move oncology and immunology candidates toward clinical trials.